Vincent Mikula
Family · Warren, OHNPI 1851911655
Payments from drug & device makers
Across 158 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$429
- Lilly USA, LLC$400
- Amarin Pharma, Inc.$317
- Amgen$182
- Boehringer Ingelheim$144
- Bayer$131
- plus $623 from 12 others
What the payments were for
- Food & beverage$2,21699%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 29 | $429 |
| Lilly USA, LLC | 29 | $400 |
| Amarin Pharma, Inc. | 30 | $317 |
| Amgen | 13 | $182 |
| Boehringer Ingelheim | 10 | $144 |
| Bayer | 8 | $131 |
| AbbVie | 8 | $123 |
| AstraZeneca | 6 | $102 |
| Pfizer | 6 | $87 |
| Novartis | 4 | $57 |
| Medtronic | 1 | $55 |
| Johnson & Johnson | 3 | $39 |
| Esperion Therapeutics, Inc. | 3 | $38 |
| Exact Sciences | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| GSK | 2 | $27 |
| Grifols USA, LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
How this compares
$2,227 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $36,979 |
| JardianceEmpagliflozin | 26 | $33,824 |
| OzempicSemaglutide | 17 | $17,958 |
| XareltoRivaroxaban | 16 | $13,684 |
| FarxigaDapagliflozin Propanediol | 15 | $12,652 |
| LantusInsulin Glargine,hum.Rec.Anlog | 14 | $2,275 |
| SynthroidLevothyroxine Sodium | 29 | $1,507 |
| Rosuvastatin Calcium | 94 | $1,297 |
| Atorvastatin Calcium | 145 | $1,277 |
| Levothyroxine Sodium | 177 | $1,009 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $939 |
| Omeprazole | 59 | $884 |
| Gabapentin | 31 | $831 |
| Metoprolol Succinate | 64 | $726 |
| Metformin Hcl | 92 | $725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $87 | $36,97927 claims |
| Boehringer IngelheimJardiance | $144 | $33,82426 claims |
| Novo NordiskOzempic | $429 | $17,95817 claims |
| Johnson & JohnsonXarelto | $39 | $13,68416 claims |
| AstraZenecaFarxiga | $102 | $12,65215 claims |
| AbbVieSynthroid | $123 | $1,50729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.
Other family in Warren
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.